Anthera Pharmaceuticals, Inc, a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated autoimmune diseases, including immunoglobulin A nephropathy or IgA nephropathy.
Read More…
Industry, Sector and Symbol
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Phone510-856-5600
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$140,000.00
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableOptionable
Anthera Pharmaceuticals (OTCMKTS:ANTH) Frequently Asked Questions
What is Anthera Pharmaceuticals' stock symbol?
Anthera Pharmaceuticals trades on the OTCMKTS under the ticker symbol "ANTH."
When did Anthera Pharmaceuticals' stock split? How did Anthera Pharmaceuticals' stock split work?
Anthera Pharmaceuticals shares reverse split before market open on Monday, May 1st 2017. The 1-8 reverse split was announced on Friday, April 28th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Friday, April 28th 2017. An investor that had 100 shares of Anthera Pharmaceuticals stock prior to the reverse split would have 13 shares after the split.
How were Anthera Pharmaceuticals' earnings last quarter?
Anthera Pharmaceuticals Inc (OTCMKTS:ANTH) posted its quarterly earnings data on Monday, March, 5th. The biopharmaceutical company reported ($0.73) earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of ($0.82) by $0.09. View Anthera Pharmaceuticals' Earnings History.
Has Anthera Pharmaceuticals been receiving favorable news coverage?
News coverage about ANTH stock has been trending neutral this week, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Anthera Pharmaceuticals earned a news sentiment score of 0.2 on InfoTrie's scale. They also gave press coverage about the biopharmaceutical company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for Anthera Pharmaceuticals.
Who are some of Anthera Pharmaceuticals' key competitors?
Some companies that are related to Anthera Pharmaceuticals include Aileron Therapeutics (ALRN), Tetraphase Pharmaceuticals (TTPH), Oncolytics Biotech (ONCY), iCo Therapeutics (ICOTF), IMMURON LTD/S (IMRN), Mabvax Therapeutics (MBVX), Pivot Pharmaceuticals (PVOTF), Capricor Therapeutics (CAPR), Eyegate Pharmaceuticals (EYEG), GT Biopharma (GTBP), Kaya (KAYS), THERAPIX BIOSCI/S (TRPX), X T L Biopharmaceuticals (XTLB), Neurotrope (NTRP) and BENITEC BIOPHAR/S (BNTC).
What other stocks do shareholders of Anthera Pharmaceuticals own?
Who are Anthera Pharmaceuticals' key executives?
Anthera Pharmaceuticals' management team includes the folowing people:
- Mr. Paul F. Truex, Exec. Chairman (Age 49)
- Mr. John Craig Thompson, Pres, CEO & Director (Age 51)
- Dr. Renee Martin Ph.D., Sr. VP of Medical Sciences (Age 49)
- Dr. William R. Shanahan Jr., M.D., J.D., Chief Medical Officer & Sr. VP (Age 69)
- Ms. May Liu, Chief Accounting Officer, Sr. VP of Fin. & Admin. and Compliance Officer (Age 42)
How do I buy shares of Anthera Pharmaceuticals?
Shares of ANTH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Anthera Pharmaceuticals' stock price today?
One share of ANTH stock can currently be purchased for approximately $0.06.
How big of a company is Anthera Pharmaceuticals?
What is Anthera Pharmaceuticals' official website?
How can I contact Anthera Pharmaceuticals?
Anthera Pharmaceuticals' mailing address is 25801 INDUSTRIAL BOULEVARD SUITE B, HAYWARD CA, 94545. The biopharmaceutical company can be reached via phone at 510-856-5600.
MarketBeat Community Rating for Anthera Pharmaceuticals (OTCMKTS ANTH)
MarketBeat's community ratings are surveys of what our community members think about Anthera Pharmaceuticals and other stocks. Vote "Outperform" if you believe ANTH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ANTH will underperform the S&P 500 over the long term. You may vote once every thirty days.
